3560 results
Type of content
News Remove News filter
-
List item
News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 2023
CVMP, Last updated: 12/10/2023 -
List item
News: Monitoring of products originating from Japan for the possibility of radioactivity
Last updated: 11/10/2023 -
List item
News: EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
CHMP, Last updated: 05/10/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023
PRAC, Last updated: 29/09/2023 -
List item
News: EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep
CHMP, Last updated: 28/09/2023 -
List item
News: EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants
Last updated: 07/06/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023
CHMP, Last updated: 26/05/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023
PRAC, Last updated: 22/05/2023 -
List item
News: Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects
Last updated: 22/05/2023 -
List item
News: EU recommendations for 2023-2024 seasonal flu vaccine composition
CHMP, Last updated: 04/04/2023 -
List item
News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 2022
CVMP, Last updated: 15/03/2023 -
List item
News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023
CVMP, Last updated: 10/03/2023 -
List item
News: EMA update on shortages of antibiotics in the EU
Last updated: 06/02/2023 -
List item
News: Joint statement by Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on shortages of antibiotic medicines
Last updated: 20/01/2023 -
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
CHMP, Last updated: 13/01/2023 -
List item
News: EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine
CHMP, Last updated: 11/11/2022 -
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
CHMP, Last updated: 22/09/2022 -
List item
News: Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan
Last updated: 02/09/2022 -
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market
CMDh, Last updated: 26/07/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines
CHMP, Last updated: 12/11/2021 -
List item
News: Call for expressions of interest for civil society representatives to participate in work of EMA
PRAC, Last updated: 27/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021